Literature DB >> 25225110

The p60 and NamA autolysins from Listeria monocytogenes contribute to host colonization and induction of protective memory.

Ceena Chandrabos1, Saïdi M'Homa Soudja, Brian Weinrick, Marilyn Gros, Aurel Frangaj, Massilva Rahmoun, William R Jacobs, Grégoire Lauvau.   

Abstract

Inducing long-term protective memory CD8(+) T-cells is a desirable goal for vaccines against intracellular pathogens. However, the mechanisms of differentiation of CD8(+) T-cells into long-lived memory cells capable of mediating protection of immunized hosts remain incompletely understood. We have developed an experimental system using mice immunized with wild type (WT) or mutants of the intracellular bacterium Listeria monocytogenes (Lm) that either do or do not develop protective memory CD8(+) T-cells. We previously reported that mice immunized with Lm lacking functional SecA2, an auxiliary secretion system of gram-positive bacteria, did not differentiate functional memory CD8(+) T-cells that protected against a challenge infection with WT Lm. Herein we hypothesized that the p60 and NamA autolysins of Lm, which are major substrates of the SecA2 pathway, account for this phenotype. We generated Lm genetically deficient for genes encoding for the p60 and NamA proteins, ΔiapΔmurA Lm, and further characterized this mutant. Δp60ΔNamA Lm exhibited a strong filamentous phenotype, inefficiently colonized host tissues, and grew mostly outside cells. When Δp60ΔNamA Lm was made single unit, cell invasion was restored to WT levels during vaccination, yet induced memory T-cells still did not protect immunized hosts against recall infection. Recruitment of blood phagocytes and antigen-presenting cell activation was close to that of mice immunized with ΔActA Lm, which develop protective memory. However, key inflammatory factors involved in optimal T-cell programming such as IL-12 and type I IFN (IFN-I) were lacking, suggesting that cytokine signals may largely account for the observed phenotype. Thus, altogether, these results establish that p60 and NamA secreted by Lm promote primary host cell invasion, the inflammatory response and the differentiation of functional memory CD8(+) T-cells, by preventing Lm filamentation during growth and subsequent triggering of innate sensing mechanisms.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225110      PMCID: PMC4457399          DOI: 10.1111/cmi.12362

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  46 in total

1.  c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response.

Authors:  Joshua J Woodward; Anthony T Iavarone; Daniel A Portnoy
Journal:  Science       Date:  2010-05-27       Impact factor: 47.728

2.  Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.

Authors:  Erwan Mortier; Rommel Advincula; Leesun Kim; Stephen Chmura; Julio Barrera; Boris Reizis; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2009-11-12       Impact factor: 31.745

3.  Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation.

Authors:  Hélène Beuneu; Jacques Deguine; Isabelle Bouvier; James P Di Santo; Matthew L Albert; Philippe Bousso
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

Review 4.  Monocyte recruitment during infection and inflammation.

Authors:  Chao Shi; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

5.  Priming of protective anti-Listeria monocytogenes memory CD8+ T cells requires a functional SecA2 secretion system.

Authors:  Massilva Rahmoun; Marilyn Gros; Laura Campisi; Delphine Bassand; Anne Lazzari; Christophe Massiera; Emilie Narni-Mancinelli; Pierre Gounon; Grégoire Lauvau
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

6.  Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge.

Authors:  Jacob E Kohlmeier; Tres Cookenham; Alan D Roberts; Shannon C Miller; David L Woodland
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

7.  Splenic CD8α⁺ dendritic cells undergo rapid programming by cytosolic bacteria and inflammation to induce protective CD8⁺ T-cell memory.

Authors:  Laura Campisi; Saidi M'Homa Soudja; Julie Cazareth; Delphine Bassand; Anne Lazzari; Frédéric Brau; Emilie Narni-Mancinelli; Nicolas Glaichenhaus; Frédéric Geissmann; Grégoire Lauvau
Journal:  Eur J Immunol       Date:  2011-05-25       Impact factor: 5.532

Review 8.  From vaccines to memory and back.

Authors:  Federica Sallusto; Antonio Lanzavecchia; Koichi Araki; Rafi Ahmed
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

9.  CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes.

Authors:  Brian T Edelson; Tara R Bradstreet; Kai Hildner; Javier A Carrero; Katherine E Frederick; Wumesh KC; Roger Belizaire; Taiki Aoshi; Robert D Schreiber; Mark J Miller; Theresa L Murphy; Emil R Unanue; Kenneth M Murphy
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

10.  Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.

Authors:  Emilie Narni-Mancinelli; Laura Campisi; Delphine Bassand; Julie Cazareth; Pierre Gounon; Nicolas Glaichenhaus; Grégoire Lauvau
Journal:  J Exp Med       Date:  2007-08-13       Impact factor: 14.307

View more
  2 in total

Review 1.  The Two Distinct Types of SecA2-Dependent Export Systems.

Authors:  Miriam Braunstein; Barbara A Bensing; Paul M Sullam
Journal:  Microbiol Spectr       Date:  2019-05

2.  Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics.

Authors:  Ekaterina Taneva; Shada Sinclair; Pedro Mm Mesquita; Brian Weinrick; Scott A Cameron; Natalia Cheshenko; Kerry Reagle; Bruce Frank; Sujatha Srinivasan; David Fredricks; Marla J Keller; Betsy C Herold
Journal:  JCI Insight       Date:  2018-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.